DNA methylation in stem cell renewal and multipotencyA role for methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1 geneDynamics of DNA methylation in recent human and great ape evolutionFrequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancerThe loss of NKX3.1 expression in testicular--and prostate--cancers is not caused by promoter hypermethylationMutator pathways unleashed by epigenetic silencing in human cancerNotch signaling is essential for ventricular chamber developmentThe Polycomb group protein EZH2 directly controls DNA methylationA genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cellsA truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibitionCombinatorial effects of splice variants modulate function of AiolosWNT10B functional dualism: beta-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancerEpigenetic differences arise during the lifetime of monozygotic twinsAllele-specific histone lysine methylation marks regulatory regions at imprinted mouse genes.Distinct DNA methylomes of newborns and centenariansGATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancerThe chromatin remodeling factor CHD8 interacts with elongating RNA polymerase II and controls expression of the cyclin E2 genehMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesisA CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell linesTumor-Related Molecular Mechanisms of Oxaliplatin ResistanceBreast cancer epigenetics: from DNA methylation to microRNAsInactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.Unique genomic profile of fibrolamellar hepatocellular carcinoma.MiR-221/222 target the DNA methyltransferase MGMT in glioma cellsHypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational statusDNA methylation: a profile of methods and applicationsInactivation of LKB1/STK11 is a common event in adenocarcinomas of the lungA gene hypermethylation profile of human cancerA DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effectLoss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerThe necessity of a human epigenome projectEpigenetic inactivation of the premature aging Werner syndrome gene in human cancerCpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancerMLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomasGenetic unmasking of an epigenetically silenced microRNA in human cancer cellsEpigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancerDetection of clonality and genetic alterations in endometrial pipelle biopsy and its surgical specimen counterpart31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part oneToward understanding and exploiting tumor heterogeneityCancer epigenomics: DNA methylomes and histone-modification maps
P50
P98
Q21128656-FDF2A698-1135-4A7B-88C2-CB6DE5573ADEQ21142628-C1C494C3-5E79-48CD-841E-59F6898A6B03Q21144886-AC85D974-2FC1-4F9A-8780-A3BA4FBED2E0Q21195213-63080217-60BE-4F04-9392-B64164E30E07Q21245744-F1DB1D47-E90D-4F85-9C49-A30A40855AF2Q22242850-40B1D68C-26CE-429E-916F-AB06F07AA7A8Q24299001-1F2BE5AA-BC3C-43D5-A4DE-5D25C10C1B32Q24299020-83F9C0EF-EE1A-49D9-AB23-00FAAB0AFFA7Q24303520-2EED5B02-9AFD-4E8D-AA24-E7ED65A5DA0CQ24321639-65D7F275-E32F-4A28-BA5A-B4DCAECBFF01Q24321807-76F57FE4-CD5C-4D75-98E6-F56FB66B8D34Q24338737-2B3F8CEE-236A-4300-9AFB-CE63466009D8Q24531005-19FF169E-1FB0-4E6B-85DC-C1462B10E80DQ24539228-065EB752-80D3-4ACF-B03D-2FC17E04B112Q24595040-251B1C14-0072-43BC-8AA9-2B5AAC98EF5FQ24648331-F8321D9E-D8E3-4E73-8CFD-C4F9FC0AC915Q24649565-AD2892AE-7BE4-49B6-A589-0D697FD24A58Q24670424-D27B736E-520E-470A-8BE7-667738A5F3AAQ24792846-ED6DAD9B-08E6-4609-BDE5-E047E5A1058DQ26799848-77A4DF0D-CF26-4603-9142-B3247F95C1DDQ27694164-1BEB820A-C5E7-4F11-93DF-EE52BA1B6EDCQ27777800-24C279B0-C173-49EB-9F1D-99B99DB82637Q27853116-B9DAC054-8DC3-49AD-A811-7BCBD8BCE5F8Q28118866-6B0B995A-D4EE-47FE-86EA-4EDAF57448F5Q28143274-47CDA2C7-B50B-489F-B734-B2618FAFE6B1Q28202469-05CE3DE3-F7AA-4C21-9D2D-AE8975D31EFAQ28208680-424EAD7B-2712-4C09-939B-8432D5A91CB4Q28213253-7D0FEB77-370D-41DA-A926-182FE8131601Q28237387-408A0726-0317-47B1-AD38-0A50BF371E68Q28239595-565C0261-335B-47A1-B843-814ADA513A23Q28240080-06DA42BC-D63D-47F8-B01F-B7B421567B57Q28242111-2B415224-6CCC-4E04-9F0B-8892EF4EBD05Q28283044-78B8F4DF-D014-4C03-A678-66E3CCD457DCQ28288475-972F0CAE-A74F-462D-ADA5-A071A4665830Q28288806-7D434DBE-D505-45AA-8A6A-6DFD558E149AQ28298475-52493D68-A1EF-43BD-875D-540D191520E9Q28302287-00D8BDEF-9CD4-42AB-AC09-660BF195C521Q28553703-A5148CED-AF65-4AD2-96DC-CBC4512084C9Q28603034-5C92EFF4-78CF-467E-A338-3C5114930991Q29615524-ADE0FC82-1775-441C-8F2D-5A67B8FAAB31
P50
description
Catalan geneticist and medical doctor
@en
Spaans klinische genetica
@nl
científico español
@es
dokter asal Spanyol
@id
genetista i metge català
@ca
name
Manel Esteller
@ast
Manel Esteller
@ca
Manel Esteller
@de
Manel Esteller
@en
Manel Esteller
@es
Manel Esteller
@fr
Manel Esteller
@ga
Manel Esteller
@nl
Manel Esteller
@sl
Manel Esteller
@sq
type
label
Manel Esteller
@ast
Manel Esteller
@ca
Manel Esteller
@de
Manel Esteller
@en
Manel Esteller
@es
Manel Esteller
@fr
Manel Esteller
@ga
Manel Esteller
@nl
Manel Esteller
@sl
Manel Esteller
@sq
altLabel
Manel Esteller Badosa
@es
Manel Esteller
@en
prefLabel
Manel Esteller
@ast
Manel Esteller
@ca
Manel Esteller
@de
Manel Esteller
@en
Manel Esteller
@es
Manel Esteller
@fr
Manel Esteller
@ga
Manel Esteller
@nl
Manel Esteller
@sl
Manel Esteller
@sq